Not applicableStudy completedNCT02428114
What this trial is testing
A Multi Centre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Standard of Care Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia in Early Stage Breast Cancer (React-G Study)
Who this might be right for
Early Stage Breast Cancer
Ottawa Hospital Research Institute 142